. 2013 Sep 17;170(3):679–692. doi: 10.1111/bph.12321

Table 1.

Experimental design and pCB content of in vivo Experiments 1.1–4.2

Experiment/Figures	Compound	Doses (mg·kg⁻¹)	CBDV/CBD content (mg·kg⁻¹)	THC/THCV content (mg·kg⁻¹)
Experiment 1.1, Figure 1A and 1B	Modified CBDV BDS	50	29/7	0/0
		100	58/14	0/0
		200	116/27	0/0
		275	159/38	0/0
		346	200/47	0/0
Experiment 1.2, Figure 1C and 1D	Purified CBDV	50	50/0	0/0
		100	100/0	0/0
		200	200/0	0/0
	Modified CBDV BDS	50	29/7	0/0
		100	58/14	0/0
		200	116/27	0/0
Experiment 1.3, Figure 1E and 1F	Purified CBDV + CBD	Low	50/12	0/0
		Mid	100/23	0/0
		High	200/47	0/0
	Modified CBDV BDS	50	50/12	0/0
		100	100/23	0/0
		200	200/47	0/0
Experiment 1.4, Figure 1G and 1H	pCB-free BDS	50	2/<1	0/0
		100	4/<1	0/0
		200	9/<1	0/0
Experiments 2.1 and 2.2, Figure 2A–F	Unmodified CBDV BDS	150	71/21	2/4
		275	130/38	3/7
		422	200/59	4/11
	Modified CBDV BDS	150	87/21	0/0
		275	159/38	0/0
		346	200/47	0/0
Experiment 3.1, Figure 3A	Unmodified CBDV BDS	50	24/7	1/1
		100	47/14	1/3
		200	95/28	2/5
Experiment 3.2, Figure 3B	Modified CBDV BDS	50	29/7	0/0
		100	58/14	0/0
		200	116/27	0/0
Experiment 4.1, Figure 4A	Unmodified CBDV BDS	100	47/14	1/3
		200	95/28	2/5
		300	142/42	3/8
Experiment 4.2, Figure 4B	Modified CBDV BDS	200	116/27	0/0
	Unmodified CBDV BDS	200	116/28	2/5
	CBDV + CBD	–	116/27	0/0